Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus clonidine plus sufentanil for bleeding control during endoscopic sinus surgery
ACTRN12614000935639Phase 4Completed
- Sponsor
- Laurent Bairy
- Start
- Nov 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic rhinosinusitis (CRS) comparing Clonidine + sufentanil group with Remifentanil group (2 arms). Primary endpoint: Fromme score. Started Nov 2014; status: completed.
02
Drugs
remifentanilclonidinesufentanil
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12614000935639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000935639.